Subscribe to Newsletter

Formulation

Discovery & Development Drug Discovery

Targeting Alopecia with Plant Power

| Saad Harti | 8 min read

A drug development story: how one company filed a marketing authorization in Europe for a botanical drug to treat alopecia areata.

Discovery & Development Drug Delivery

Taking Vaccines Beyond Borders

| Jamie Irvine | 3 min read

Can yeast-based vaccines help overcome global vaccine inequity challenges?

Discovery & Development Drug Discovery

Minds, Interrupted

| Ashlea Segal, Alex Fornito | 2 min read

Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders

Discovery & Development Drug Discovery

Alzheimer’s Disease: The Winds of Progress

| Jamie Irvine | 10 min read

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope

Discovery & Development Ingredients

Manufacturers Urged to Take Steps to Avoid DEG and EG Contamination

| Stephanie Vine | 4 min read

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Discovery & Development Drug Discovery

Reaching for RNA

| Stephanie Vine | 7 min read

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Discovery & Development Formulation

The Sulforaphane Promise

| Helen Kuhlman | 4 min read

Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?

Discovery & Development Drug Discovery

Llamas Versus Dengue

| Stephanie Vine | 3 min read

Why one company is focusing on camelid-derived antibodies to tackle dengue.

Discovery & Development Drug Discovery

Exploring Alzheimer’s in Women

| Jamie Irvine | 2 min read

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Discovery & Development Drug Delivery

The Realities of Herbal Remedies

| Jamie Irvine | 3 min read

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine


Latest White Papers

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

LC-MS/MS method for the quantification of 10 nitrosamine impurities in metformin

| Contributed by Thermo Fisher Scientific

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register